Evolving Importance of Clinical Outcome Assessments in Drug Development

The chapter discusses the shift towards formalizing procedures for developing and interpreting clinical outcome assessments (COAs), emphasizing a patient-centric approach. It explores the evolution of COAs and patient-reported outcome measures driven by patient demand and regulatory interest, highlighting the significance of patient-reported outcomes (PROs) and the guidance for their inclusion in research.